Skip to main content

CAPROCK Group, Inc.

SEC CIK
0001610769
Latest filing
Jul 27, 2026

ABT holding history

Abbott Laboratories in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
39,087
Value
$3.55M
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of ABT by CAPROCK Group, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202639,087$3.55M0.1%−8,990−18.7%ReducedHolders
Q1 202648,077$4.94M0.1%−19,959−29.3%ReducedHolders
Q4 202568,036$8.52M0.2%+3,706+5.8%AddedHolders
Q3 202564,330$8.53M0.2%–No prior filingHolders
Q2 2025––––Not filedHolders
Q1 202560,058$7.97M0.2%+5,961+11.0%AddedHolders
Q4 202454,097$6.12M0.2%+6,022+12.5%AddedHolders
Q3 202448,075$5.48M0.2%+3,591+8.1%AddedHolders
Q2 202444,484$4.62M0.2%+14,107+46.4%AddedHolders
Q1 202430,377$3.45M0.2%+1,044+3.6%AddedHolders
Q4 202329,333$3.23M0.2%+15+0.1%AddedHolders
Q3 202329,318$2.84M0.2%+1,772+6.4%AddedHolders
Q2 202327,546$3.00M0.2%+3,580+14.9%AddedHolders
Q1 202323,966$2.43M0.2%+1,843+8.3%AddedHolders
Q4 202222,123$2.43M0.2%+1,261+6.0%AddedHolders
Q3 202220,862$2.02M0.2%+388+1.9%AddedHolders
Q2 202220,474$2.23M0.2%+1,672+8.9%AddedHolders
Q1 202218,802$2.23M0.2%+2,084+12.5%AddedHolders
Q4 202116,718$2.35M0.2%−2,667−13.8%ReducedHolders
Q3 202119,385$2.29M0.2%+2,501+14.8%AddedHolders
Q2 202116,884$1.96M0.2%−1,979−10.5%ReducedHolders
Q1 202118,863$2.26M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.